Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuaki Sagara

Showing results (41-50 of 131) with videos related to

Pageof 14
Sort By:
Cancers|January 28, 2021
Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma DiagnosisKodai Nakamura, Naomi Hiyake, Tomofumi Hamada, et al.
The Journal of Clinical Investigation|January 3, 2015
F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous mannerKanae Yumimoto, Sayuri Akiyoshi, Hiroki Ueo, et al.
NPJ Breast Cancer|May 9, 2026
Risk factors and metastatic sites in HER2-positive breast cancer with pathological complete responseMayako Terao, Hiraku Kumamaru, Naoko Kinukawa, et al.
Breast Cancer (Tokyo, Japan)|August 11, 2007
Clear cell hidradenoma of the breast: a case report with review of the literatureYasuyo Ohi, Yoshihisa Umekita, Yoshiaki Rai, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2018
Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC)Takahiro Nakayama, Yasuaki Sagara, Tsutomu Takashima, et al.
JCO Clinical Cancer Informatics|September 15, 2025
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort StudyYasuaki Sagara, Atsushi Yoshida, Yuri Kimura, et al.
Breast Cancer (Tokyo, Japan)|June 9, 2025
Impact of margin status on ipsilateral breast tumor recurrence after breast-conserving treatment for patients with breast cancer who received neoadjuvant chemotherapy: a retrospective multi-institutional study of 1813 casesMakoto Ishitobi, Atsushi Yoshida, Yuri Kimura, et al.
Breast Cancer (Tokyo, Japan)|April 8, 2026
Changes in re-excision rates after publication of guidelines defining positive margins for breast-conserving surgery: a collaborative study of the Japanese breast cancer societyTakehiko Sakai, Yuri Kimura, Makoto Ishitobi, et al.
Breast Cancer (Tokyo, Japan)|December 29, 2011
Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancerYasuaki Sagara, Yasuyo Ohi, Ayami Matsukata, et al.
The Lancet. Oncology|January 24, 2012
Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trialNorikazu Masuda, Yasuaki Sagara, Takayuki Kinoshita, et al.
Pageof 14

Showing results (41-50 of 131) with videos related to

Sort By:
Pageof 14
Cancers|January 28, 2021
Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma DiagnosisKodai Nakamura, Naomi Hiyake, Tomofumi Hamada, et al.
The Journal of Clinical Investigation|January 3, 2015
F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous mannerKanae Yumimoto, Sayuri Akiyoshi, Hiroki Ueo, et al.
NPJ Breast Cancer|May 9, 2026
Risk factors and metastatic sites in HER2-positive breast cancer with pathological complete responseMayako Terao, Hiraku Kumamaru, Naoko Kinukawa, et al.
Breast Cancer (Tokyo, Japan)|August 11, 2007
Clear cell hidradenoma of the breast: a case report with review of the literatureYasuyo Ohi, Yoshihisa Umekita, Yoshiaki Rai, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2018
Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC)Takahiro Nakayama, Yasuaki Sagara, Tsutomu Takashima, et al.
JCO Clinical Cancer Informatics|September 15, 2025
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort StudyYasuaki Sagara, Atsushi Yoshida, Yuri Kimura, et al.
Breast Cancer (Tokyo, Japan)|June 9, 2025
Impact of margin status on ipsilateral breast tumor recurrence after breast-conserving treatment for patients with breast cancer who received neoadjuvant chemotherapy: a retrospective multi-institutional study of 1813 casesMakoto Ishitobi, Atsushi Yoshida, Yuri Kimura, et al.
Breast Cancer (Tokyo, Japan)|April 8, 2026
Changes in re-excision rates after publication of guidelines defining positive margins for breast-conserving surgery: a collaborative study of the Japanese breast cancer societyTakehiko Sakai, Yuri Kimura, Makoto Ishitobi, et al.
Breast Cancer (Tokyo, Japan)|December 29, 2011
Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancerYasuaki Sagara, Yasuyo Ohi, Ayami Matsukata, et al.
The Lancet. Oncology|January 24, 2012
Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trialNorikazu Masuda, Yasuaki Sagara, Takayuki Kinoshita, et al.
Pageof 14